Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Malignant Melanoma

Free Subscription Articles published in Oncogene Retrieve available abstracts of 47 articles: HTML format Text format

Single Articles

January 2012
1. ZHANG K , Wong P, Zhang L, Jacobs B, et al
   A Notch1-neuregulin1 autocrine signaling loop contributes to melanoma growth.
   Oncogene. 2012 Jan 16. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
2. RODRIGUEZ MI , Gonzalez-Flores A, Dantzer F, Collard J, et al
   Poly(ADP-ribose)-dependent regulation of Snail1 protein stability.
   Oncogene. 2011;30:4365-72.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
3. THU YM , Su Y, Yang J, Splittgerber R, et al
   NF-kappaB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the beta-catenin pathway.
   Oncogene. 2011 Oct 3. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
4. CHELI Y , Giuliano S, Fenouille N, Allegra M, et al
   Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells.
   Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. BASILE KJ , Abel EV, Aplin AE
   Adaptive upregulation of FOXD3 and resistance to PLX4032/4720-induced cell death in mutant B-RAF melanoma cells.
   Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. LI W , Melton DW
   Cisplatin regulates the MAPK kinase pathway to induce increased expression of DNA repair gene ERCC1 and increase melanoma chemoresistance.
   Oncogene. 2011 Sep 26. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. GANGULY SS , Fiore LS, Sims JT, Friend JW, et al
   c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression.
   Oncogene. 2011 Sep 5. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
8. KUMAR SM , Zhang G, Bastian BC, Arcasoy MO, et al
   Erythropoietin receptor contributes to melanoma cell survival in vivo.
   Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. STREICHER KL , Zhu W, Lehmann KP, Georgantas RW, et al
   A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
   Oncogene. 2011 Aug 22. doi: 10.1038/onc.2011.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. LEE J , Li L, Gretz N, Gebert J, et al
    Absent in Melanoma 2 (AIM2) is an important mediator of interferon-dependent and -independent HLA-DRA and HLA-DRB gene expression in colorectal cancers.
    Oncogene. 2011 Aug 1. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
11. OH JH , Cho MC, Kim JH, Lee SY, et al
    IL-32gamma inhibits cancer cell growth through inactivation of NF-kappaB and STAT3 signals.
    Oncogene. 2011;30:3345-59.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. DE LANGE J , Ly LV, Lodder K, Verlaan-de Vries M, et al
    Synergistic growth inhibition based on small-molecule p53 activation as treatment for intraocular melanoma.
    Oncogene. 2011 Jul 18. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. VERHAEGEN M , Checinska A, Riblett MB, Wang S, et al
    E2F1-dependent oncogenic addiction of melanoma cells to MDM2.
    Oncogene. 2011 Jul 11. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. XING F , Persaud Y, Pratilas CA, Taylor BS, et al
    Concurrent loss of the PTEN and RB1 tumor suppressors attenuates RAF dependence in melanomas harboring (V600E)BRAF.
    Oncogene. 2011 Jul 4. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. LUO Y , Zheng C, Zhang J, Lu D, et al
    Recognition of CD146 as an ERM-binding protein offers novel mechanisms for melanoma cell migration.
    Oncogene. 2011 Jul 4. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
16. FENOUILLE N , Puissant A, Tichet M, Zimniak G, et al
    SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
    Oncogene. 2011 Jun 20. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. UDAYAKUMAR D , Zhang G, Ji Z, Njauw CN, et al
    Epha2 is a critical oncogene in melanoma.
    Oncogene. 2011 Jun 13. doi: 10.1038/onc.2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
18. YANG D , Tao J, Li L, Kedei N, et al
    RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. CHELI Y , Giuliano S, Botton T, Rocchi S, et al
    Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
    Oncogene. 2011;30:2390.
    PubMed     Text format     Related articles   
    
    
    
    
20. AROZARENA I , Bischof H, Gilby D, Belloni B, et al
    In melanoma, beta-catenin is a suppressor of invasion.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
21. HASSAN M , Alaoui A, Feyen O, Mirmohammadsadegh A, et al
    The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways.
    Oncogene. 2011;30:2086.
    PubMed     Text format     Related articles   
    
    
    
    
22. SHAO H , Cai L, Grichnik JM, Livingstone AS, et al
    Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1.
    Oncogene. 2011.
    PubMed     Text format     Related articles   
    
    
    
    
23. MISHRA PJ , Ha L, Rieker J, Sviderskaya EV, et al
    Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation.
    Oncogene. 2011;30:1850.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
24. HUYNH C , Segura MF, Gaziel-Sovran A, Menendez S, et al
    Efficient in vivo microRNA targeting of liver metastasis.
    Oncogene. 2011;30:1481-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. DONG L , Jiang CC, Thorne RF, Croft A, et al
    Ets-1 mediates upregulation of Mcl-1 downstream of XBP-1 in human melanoma cells upon ER stress.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
26. THURBER AE , Douglas G, Sturm EC, Zabierowski SE, et al
    Inverse expression states of the BRN2 and MITF transcription factors in melanoma spheres and tumour xenografts regulate the NOTCH pathway.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
27. CHELI Y , Guiliano S, Botton T, Rocchi S, et al
    Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. WANI AA , Jafarnejad SM, Zhou J, Li G, et al
    Integrin-linked kinase regulates melanoma angiogenesis by activating NF-kappaB/interleukin-6 signaling pathway.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. GODING CR
    A picture of Mitf in melanoma immortality.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. STRUB T , Giuliano S, Ye T, Bonet C, et al
    Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma.
    Oncogene. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. DE CARVALHO DD , Binato R, Pereira WO, Leroy JM, et al
    BCR-ABL-mediated upregulation of PRAME is responsible for knocking down TRAIL in CML patients.
    Oncogene. 2011;30:223-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
32. GODSHALK SE , Paranjape T, Nallur S, Speed W, et al
    A Variant in a MicroRNA complementary site in the 3' UTR of the KIT oncogene increases risk of acral melanoma.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2010
33. LI J , Cheng Y, Tai D, Martinka M, et al
    Prognostic significance of BRMS1 expression in human melanoma and its role in tumor angiogenesis.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
34. LI C , Xin W, Sy MS
    Binding of pro-prion to filamin A: by design or an unfortunate blunder.
    Oncogene. 2010;29:5329-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. PARDALI E , van der Schaft DW, Wiercinska E, Gorter A, et al
    Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. HORNLE M , Peters N, Thayaparasingham B, Vorsmann H, et al
    Caspase-3 cleaves XIAP in a positive feedback loop to sensitize melanoma cells to TRAIL-induced apoptosis.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
37. KAPLAN FM , Shao Y, Mayberry MM, Aplin AE, et al
    Hyperactivation of MEK-ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
38. FUKUNAGA-KALABIS M , Martinez G, Nguyen TK, Kim D, et al
    Tenascin-C promotes melanoma progression by maintaining the ABCB5-positive side population.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. NOGUEIRA C , Kim KH, Sung H, Paraiso KH, et al
    Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. DAVIES MA , Samuels Y
    Analysis of the genome to personalize therapy for melanoma.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. MONAHAN KB , Rozenberg GI, Krishnamurthy J, Johnson SM, et al
    Somatic p16(INK4a) loss accelerates melanomagenesis.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2010
42. ZIPFEL PA , Brady DC, Kashatus DF, Ancrile BD, et al
    Ral activation promotes melanomagenesis.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
43. BOUKERCHE H , Aissaoui H, Prevost C, Hirbec H, et al
    Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of nuclear factor-kappaB.
    Oncogene. 2010;29:3054-66.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
44. LIN Y , Chen NT, Shih YP, Liao YC, et al
    DLC2 modulates angiogenic responses in vascular endothelial cells by regulating cell attachment and migration.
    Oncogene. 2010;29:3010-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
45. CHEN G , Wang Y, Garate M, Zhou J, et al
    The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
    Oncogene. 2010;29:1498-508.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. ZANELLA F , Renner O, Garcia B, Callejas S, et al
    Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2010
47. MISHRA PJ , Ha L, Rieker J, Sviderskaya EV, et al
    Dissection of RAS downstream pathways in melanomagenesis: a role for Ral in transformation.
    Oncogene. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: